Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 20.10
+0.20 (1.01%)
At close: Aug 4, 2026
Vistin Pharma ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 891 | 922 | 1,051 | 1,033 | 701 | 859 | |
Market Cap Growth | -17.28% | -12.24% | 1.72% | 47.47% | -18.47% | 11.06% |
Enterprise Value | 885.5 | 905.96 | 1,038 | 1,007 | 744.36 | 823.66 |
Last Close Price | 20.10 | 20.80 | 23.70 | 23.30 | 15.80 | 19.38 |
PE Ratio | 11.96 | 12.31 | 16.69 | 22.62 | - | 34.61 |
Forward PE | - | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 |
PEG Ratio | - | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 |
PS Ratio | 1.98 | 2.04 | 2.45 | 2.36 | 2.30 | 3.08 |
PB Ratio | 2.54 | 2.81 | 3.40 | 3.20 | 2.56 | 3.12 |
P/TBV Ratio | 2.55 | 2.81 | 3.40 | 3.20 | 2.56 | 3.12 |
P/FCF Ratio | 17.36 | 16.62 | - | 14.21 | - | - |
P/OCF Ratio | 12.94 | 16.62 | - | 11.41 | - | 62.82 |
EV/Sales Ratio | 1.97 | 2.00 | 2.42 | 2.30 | 2.44 | 2.96 |
EV/EBITDA Ratio | 10.00 | 2.00 | 12.17 | 11.72 | 120.35 | 18.78 |
EV/EBIT Ratio | 10.00 | 2.00 | 12.17 | 14.68 | - | 24.77 |
EV/FCF Ratio | 17.25 | 16.32 | - | 13.85 | - | - |
Debt / Equity Ratio | - | 0 | 0 | 0 | 0.17 | 0 |
Debt / EBITDA Ratio | - | - | - | - | 7.30 | - |
Net Debt / Equity Ratio | -0.02 | -0.05 | -0.04 | -0.08 | 0.16 | -0.13 |
Net Debt / EBITDA Ratio | -0.07 | -0.04 | -0.15 | -0.30 | 7.07 | -0.81 |
Net Debt / FCF Ratio | - | -0.30 | - | -0.36 | -0.58 | 1.96 |
Asset Turnover | 1.01 | 1.10 | 1.09 | 1.08 | 0.82 | 0.85 |
Inventory Turnover | 1.82 | 0 | 1.91 | 2.16 | 2.19 | 2.57 |
Quick Ratio | 1.83 | 1.40 | 1.04 | 1.28 | 0.64 | 2.31 |
Current Ratio | 2.96 | 2.35 | 2.24 | 2.43 | 1.35 | 3.36 |
Return on Equity (ROE) | 21.95% | 141.71% | 19.85% | 15.29% | -2.66% | 14.27% |
Return on Assets (ROA) | 15.47% | 109.73% | 16.88% | 13.19% | -2.00% | 12.41% |
Return on Invested Capital (ROIC) | 21.04% | 148.50% | 22.43% | 17.42% | -2.66% | 18.68% |
Return on Capital Employed (ROCE) | 24.17% | 134.27% | 26.05% | 22.00% | -2.10% | 11.43% |
Earnings Yield | 8.36% | 8.13% | 5.99% | 4.42% | - | 2.89% |
FCF Yield | 5.76% | 6.02% | 0.00% | 7.04% | - | - |
Dividend Yield | 7.54% | 0.00% | 0.00% | 0.00% | 0.00% | 2.58% |
Payout Ratio | 74.36% | 0.00% | 0.00% | 0.00% | 0.00% | 89.17% |
Buyback Yield / Dilution | -0.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Shareholder Return | 7.49% | 0.00% | 0.00% | 0.00% | 0.00% | 2.58% |